A new FDA-approved trial explores innovative treatments for recurrent glioblastoma, offering hope for patients facing this ...

The U.S. Food and Drug Administration on Thursday announced a new program to strengthen the domestic pharmaceutical supply chain, by facilitating construction of manufacturing sites in the United ...